Apyx Medical Corporation (APYX) financial statements and ratios from SEC XBRL: revenue $52.84M (TTM), net margin -21.2%, revenue growth 9.9% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $52.84M |
| Net Margin | -21.2% |
| Revenue Growth (YoY) | 9.9% |
| EPS Growth (YoY) | -59.1% |
| FCF Growth (YoY) | -51.4% |
| Price / Book | 11.51 |
| Price / Sales | 2.47 |
| FCF Yield | -9.2% |
| Altman Z-Score | 0.91 (distress) |
| Piotroski F-Score | 5/9 |
| Sector P/E (Healthcare) | 21.6 |
APYX overview · APYX earnings · APYX KPIs · APYX investor relations · APYX ownership · APYX peers · APYX filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.